. Author manuscript; available in PMC: 2012 Jul 1.

Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2011 Jun 21;4(4):399–407. doi: 10.1161/CIRCOUTCOMES.110.959809

Table 3.

The proportion of antihypertensive medications prescribed at discharge and proportion which are new prescriptions for antihypertensive medications (total sum greater than 100% as some patients received more than 1 prescription)

	Discharge prescriptions N=3640 patients (%)	History of Hypertension N=2877 (%)	No history of Hypertension N=763 (%)	New prescription^* for antihypertensive at Discharge
Combination ACE/ ARB^† + Thiazide	548 (15.0)	505 (17.6)	43 (5.6)	197/548=36.0%
Thiazide diuretics	794 (21.8)	710 (24.7)	84 (11.0)	240 / 794 = 30.2%
ACEI/ARB^†	1969 (54.1)	1722(59.8)	247 (32.4)	498 / 1969 = 25.3%
Beta Blockers	1737(47.7)	1513 (52.6)	224 (29.4)	378 / 1737 = 21.8%
Calcium Channel Blockers	928 (25.5)	846 (29.4)	82 (10.8)	187 / 928 = 20.2%
Alpha adrenergic	487(13.4)	410 (14.2)	77 (10.1)	74 / 487 = 15.2%
Centrally acting agents	231(6.4)	214 (7.4)	17 (2.2)	86 / 231 = 37.2%
Other diuretics	579 (15.9)	507 (17.6)	72 (9.4)	88 / 579 = 15.2%

^†

Angiotensin Converting Enzyme Inhibitor/ Angiotensin Receptor Blocker

New prescription was determined by comparing the discharge list of medications to the admission list of medications. 2760 patients had at least 1 anti-hypertensive drug at admission and 2985 patients had at least 1 anti hypertensive drug at discharge.